The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival. The once-popular DNA-testing site will also halt work on therapies it was developing. Last year, the company said hackers had managed to gain access to personal information of millions of its users. 23andMe’s share price has fallen by more than 70% this year, as its co-founder and chief